These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7013297)

  • 1. [Causes of insulin secretion disorders in non-insulin dependent diabetics. Comparison of in vivo results with examinations of isolated islet cells].
    Lohmann D; Jahr H; Verlohren HJ; Zühlke H
    Z Gesamte Inn Med; 1981 Jan; 36(2):47-51. PubMed ID: 7013297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased glucose-induced insulin release and biosynthesis by islets of rats with non-insulin-dependent diabetes: effect of tissue culture.
    Portha B
    Endocrinology; 1985 Nov; 117(5):1735-41. PubMed ID: 3899613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement in insulin secretion in diabetes after diazoxide.
    Greenwood RH; Mahler RF; Hales CN
    Lancet; 1976 Feb; 1(7957):444-7. PubMed ID: 55717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parallel dysfunctions of pancreatic A, B and PP cells in insulin dependent diabetes.
    Nonaka K; Toyoshima H; Hanafusa T; Tarui S
    Endocrinol Jpn; 1980 Dec; 27 Suppl 1():127-33. PubMed ID: 7014203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Impact of islet alpha cell loss on insulin secretion].
    Li G; Ye L; Li J; Yang W; Lou J
    Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1427-31. PubMed ID: 12509929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cholinergic regulation of insulin and glucagon secretion in healthy people and in patients with non-insulin dependent diabetes].
    Czyźyk A; Lawecki J; Strycek-Kaminska D
    Z Gesamte Inn Med; 1981 Jan; 36(2):43-7. PubMed ID: 7013296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paradoxical enhancement of tolbutamide-induced insulin release by diazoxide in a patient with islet cell hyperplasia.
    Schikman CH; Chertow BS; Fariss BL
    Acta Paediatr Scand; 1978 Sep; 67(5):671-6. PubMed ID: 358739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon secretion from the isolated perfused rat pancreas: influenced by the glucose-, tolbutamide- and pancreozymin-mediated release of pancreatic insulin.
    Fussgänger RD; Goberna R; Laube H; Schröder KE; Straub K; Pfeiffer EF
    Isr J Med Sci; 1972 Jun; 8(6):768-9. PubMed ID: 4559419
    [No Abstract]   [Full Text] [Related]  

  • 9. Secretion of glucagon and insulin in hypophysectomized rats: effect of tolbutamide.
    Dunbar JC; Walsh MF; Foà PP
    Horm Res; 1979; 11(2):81-91. PubMed ID: 383597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inexhaustible beta cell.
    Vinik AI; Kalk WJ; Botha JL; Jackson WP; Blake KC
    Diabetes; 1976 Jan; 25(1):11-5. PubMed ID: 1107093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of islet-cell function in man.
    Arky RA; Knopp RH
    N Engl J Med; 1971 Nov; 285(20):1130-1. PubMed ID: 4937863
    [No Abstract]   [Full Text] [Related]  

  • 12. Structure-function relationships in pancreatic islets: support for intraislet modulation of insulin secretion.
    Hopcroft DW; Mason DR; Scott RS
    Endocrinology; 1985 Nov; 117(5):2073-80. PubMed ID: 2864239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogenous dysfunctions of pancreatic A and B cells in diabetes mellitus: a study by consecutive hyper-and hypoglycemic stimulation.
    Toyoshima H; Hanafusa T; Nonaka K; Tarui S
    Med J Osaka Univ; 1981 Mar; 31(3-4):93-100. PubMed ID: 7031453
    [No Abstract]   [Full Text] [Related]  

  • 14. Islet transplantation into rat liver: in vitro secretion of insulin from the isolated perfused liver and in vivo glucagon suppression.
    Charles MA; Imagawa W; Forsham PH; Grodsky GM
    Endocrinology; 1976 Mar; 98(3):738-42. PubMed ID: 131032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nervous control of pancreatic endocrine secretion in pigs. III. The effect of acetylcholine on the pancreatic secretion of insulin and glucagon.
    Holst JJ; Schaffalitzky de Muckadell OB; Fahrenkrug J; Lindkaer S; Nielsen OV; Schwartz TW
    Acta Physiol Scand; 1981 Jan; 111(1):15-22. PubMed ID: 6261532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro and in vivo effect of gold thioglucose on the insulin- and glucagon-secretion of the isolated perfused rat pancreas].
    Blech W; Bierwolf B; Weiss I; Ziegler M
    Biomed Biochim Acta; 1986; 45(4):507-22. PubMed ID: 3085662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute and chronic effects of sulfonylurea drugs on pancreatic islet function in man.
    Pfeifer MA; Halter JB; Judzewitsch RG; Beard JC; Best JD; Ward WK; Porte D
    Diabetes Care; 1984; 7 Suppl 1():25-34. PubMed ID: 6376026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptations of alpha2- and beta-cells of rat and mouse pancreatic islets to starvation, to refeeding after starvation, and to obesity.
    Matschinsky FM; Rujanavech C; Pagliara A; Norfleet WT
    J Clin Invest; 1980 Jan; 65(1):207-18. PubMed ID: 6985616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Insulin secretion in the clinical stages of diabetes (with glucose tolerance test abnormalities)].
    Vague P; Vague J
    Journ Annu Diabetol Hotel Dieu; 1972; 13(0):55-65. PubMed ID: 4605752
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies of immunoreactive insulin secretion in NZO mice in vivo.
    Cameron DP; Opat F; Insch S
    Diabetologia; 1974 Nov; 10 Suppl():649-54. PubMed ID: 4615027
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.